PwC has boosted its health industries practice with the appointment of five new partners.

Roberta Carter joined PwC in June, having previously worked at KPMG. She has worked for 25 years in the public and private health and life sciences sectors, with a focus on implementing deals and large-scale strategic change, and takes up the role of consulting and deals partner.

The other four partners are promoted from within PwC’s existing healthcare division.

Stephen Aherne is a deals partner with nearly 20 years’ experience, who heads up a team specialising in valuation and deals strategy for healthcare, pharma and life sciences. He provides valuation advice, commercial due diligence, portfolio reviews, as well as corporate and R&D strategy.

Consulting partner Steve Crook works with government and health industry clients in the UK and Europe to improve the efficiency and effectiveness of corporate support functions.

Bronwen Alexander is a transaction services partner based in London, providing financial due diligence on pharmaceutical and medtech assets to private equity and corporate clients. She has 11 years’ experience in deals, and for the last six has focused on health and pharma.

Simon Bradford is also a transaction services partner working with corporate and private equity clients. Based in Stockholm, his current focus is pharma and life sciences throughout the Nordics region. He has 10 years’ sector experience, previously working from New York and London.

Commenting on the appointments, UK health industries leader at PwC Quentin Cole said: “These partner admissions represent an investment in our senior and experienced people and lets us continue to provide the most up-to-date expertise to our clients and support the significant innovation in the healthcare sector.”